InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

TRINITY BIOTECH PLC

TRIB Clue Score23
Ireland Fiscal year ends December CIK 0000888721
$6.56 -4.30% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.56 +198.86% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue99.6Operating income−39.8Net income−100.6Fiscal year 2017Revenue99.1 −0.5%Operating income−37.7Net income−40.3Fiscal year 2018Revenue97.0 −2.1%Operating income−20.2Net income−22.1Fiscal year 2019Revenue90.4 −6.8%Operating income−24.1Net income−28.9Fiscal year 2020Revenue102.0 +12.8%Operating income0.1Net income−6.4Fiscal year 2021Revenue81.1 −20.4%Operating income3.9Net income0.9Fiscal year 2022Revenue62.5 −23.0%Operating income−19.3Net income−41.0 −4,786.7%Fiscal year 2023Revenue56.8 −9.1%Operating income−27.0Net income−24.0Fiscal year 2024Revenue61.6 +8.3%Operating income−21.2Net income−31.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue 99.6 99.1 97.0 90.4 102.0 81.1 62.5 56.8 61.6
Growth −0.5% −2.1% −6.8% +12.8% −20.4% −23.0% −9.1% +8.3%
Operating income −39.8 −37.7 −20.2 −24.1 0.1 3.9 −19.3 −27.0 −21.2
Net income −100.6 −40.3 −22.1 −28.9 −6.4 0.9 −41.0 −24.0 −31.8
Growth −4,786.7%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin43.7%Operating margin−40.0%Net margin−101.0%Free cash flow margin6.0%Fiscal year 2017Gross margin42.3%Operating margin−38.0%Net margin−40.6%Free cash flow margin4.4%Fiscal year 2018Gross margin42.7%Operating margin−20.8%Net margin−22.8%Free cash flow margin−0.3%Fiscal year 2019Gross margin42.2%Operating margin−26.7%Net margin−32.0%Free cash flow margin3.6%Fiscal year 2020Gross margin47.6%Operating margin0.1%Net margin−6.3%Free cash flow margin20.2%Fiscal year 2021Gross margin41.2%Operating margin4.9%Net margin1.1%Free cash flow margin14.1%Fiscal year 2022Gross margin27.6%Operating margin−30.9%Net margin−65.6%Free cash flow margin−3.2%Fiscal year 2023Gross margin34.2%Operating margin−47.6%Net margin−42.3%Free cash flow margin−21.7%Fiscal year 2024Gross margin34.8%Operating margin−34.4%Net margin−51.6%Free cash flow margin−7.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin 43.7% 42.3% 42.7% 42.2% 47.6% 41.2% 27.6% 34.2% 34.8%
Operating margin −40.0% −38.0% −20.8% −26.7% 0.1% 4.9% −30.9% −47.6% −34.4%
Net margin −101.0% −40.6% −22.8% −32.0% −6.3% 1.1% −65.6% −42.3% −51.6%
Free cash flow margin 6.0% 4.4% −0.3% 3.6% 20.2% 14.1% −3.2% −21.7% −7.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow10.2Capital expenditure−4.2Free cash flow6.0Buybacks−9.3Fiscal year 2017Operating cash flow9.3Capital expenditure−4.8Free cash flow4.4 −26.6%Buybacks−7.8Fiscal year 2018Operating cash flow7.2Capital expenditure−7.5Free cash flow−0.3 −106.8%Buybacks−0.4Fiscal year 2019Operating cash flow5.4Capital expenditure−2.1Free cash flow3.3Fiscal year 2020Operating cash flow23.8Capital expenditure−3.2Free cash flow20.6 +523.7%Fiscal year 2021Operating cash flow13.2Capital expenditure−1.8Free cash flow11.4 −44.5%Fiscal year 2022Operating cash flow−0.9Capital expenditure−1.1Free cash flow−2.0 −117.7%Fiscal year 2023Operating cash flow−11.6Capital expenditure−0.8Free cash flow−12.4Fiscal year 2024Operating cash flow−4.2Capital expenditure−0.4Free cash flow−4.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow 10.2 9.3 7.2 5.4 23.8 13.2 −0.9 −11.6 −4.2
Capital expenditure −4.2 −4.8 −7.5 −2.1 −3.2 −1.8 −1.1 −0.8 −0.4
Free cash flow 6.0 4.4 −0.3 3.3 20.6 11.4 −2.0 −12.4 −4.6
Growth −26.6% −106.8% +523.7% −44.5% −117.7%
Buybacks −9.3 −7.8 −0.4 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash77.1Total debt92.2Net cash (debt)−15.1Shareholders’ equity108.7Debt to equity0.85Fiscal year 2017Cash57.6Total debt93.0Net cash (debt)−35.3Shareholders’ equity65.2Debt to equity1.43Fiscal year 2018Cash30.3Total debt81.4Net cash (debt)−51.1Shareholders’ equity44.1Debt to equity1.85Fiscal year 2019Cash15.2Total debt82.0Net cash (debt)−66.8Shareholders’ equity4.7Debt to equity17.40Fiscal year 2020Cash27.3Total debt82.7Net cash (debt)−55.3Shareholders’ equity−2.2Fiscal year 2021Cash25.9Total debt83.3Net cash (debt)−57.4Shareholders’ equity−0.3Fiscal year 2022Cash6.6Total debt0.2Net cash (debt)6.4Shareholders’ equity−2.2Fiscal year 2023Cash3.7Total debt0.2Net cash (debt)3.5Shareholders’ equity−23.9Fiscal year 2024Cash5.2Total debt0.2Net cash (debt)5.0Shareholders’ equity−35.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash 77.1 57.6 30.3 15.2 27.3 25.9 6.6 3.7 5.2
Total debt 92.2 93.0 81.4 82.0 82.7 83.3 0.2 0.2 0.2
Net cash (debt) −15.1 −35.3 −51.1 −66.8 −55.3 −57.4 6.4 3.5 5.0
Shareholders’ equity 108.7 65.2 44.1 4.7 −2.2 −0.3 −2.2 −23.9 −35.2
Debt to equity 0.85 1.43 1.85 17.40 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Operations
10.2 9.3 7.2 5.4 23.8 13.2 −0.9 −11.6 −4.2
Growth −9.6% −21.8% −25.1% +338.5% −44.3% −107.0%
0.4 0.5 0.1 0.0 0.0 38.0 0.0 0.0 0.2
Investment
−4.2 −4.8 −7.5 −2.1 −3.2 −1.8 −1.1 −0.8 −0.4
calc 6.0 4.4 −0.3 3.3 20.6 11.4 −2.0 −12.4 −4.6
Growth −26.6% −106.8% +523.7% −44.5% −117.7%
calc 0.05 0.04 −0.00 0.03 0.55 0.31 −0.03 n/a n/a
−21.9 −16.2 −17.4 −11.9 −10.2 −8.7 −6.0 24.8 −23.0
Financing
−13.4 −12.6 −16.9 −7.5 −2.7 −6.0 −12.3 −16.0 28.8
−9.3 −7.8 −0.4 n/a n/a n/a n/a n/a n/a

† The diluted share count jumps at 2020 and 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.